Παρακολούθηση
Atieh Bamdadian
Atieh Bamdadian
Pharma Consultant - Digital Biomarkers
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα baselifescience.com
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
The predictive role of pre-cue EEG rhythms on MI-based BCI classification performance
A Bamdadian, C Guan, KK Ang, J Xu
Journal of neuroscience methods 235, 138–144, 2014
552014
A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data
G Pagano, FG Boess, KI Taylor, B Ricci, W Poewe, M Britschgi, ...
Frontiers in neurology 12, 705407, 2021
482021
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease
F Lipsmeier, KI Taylor, RB Postuma, E Volkova-Volkmar, T Kilchenmann, ...
Scientific reports 12 (1), 12081, 2022
342022
Improving session-to-session transfer performance of motor imagery-based BCI using adaptive extreme learning machine
A Bamdadian, C Guan, KK Ang, J Xu
2013 35th Annual International Conference of the IEEE Engineering in …, 2013
312013
Online semi-supervised learning with KL distance weighting for motor imagery-based BCI
A Bamdadian, C Guan, KK Ang, J Xu
2012 Annual International Conference of the IEEE Engineering in Medicine and …, 2012
252012
A remote digital monitoring platform to assess cognitive and motor symptoms in Huntington disease: cross-sectional validation study
F Lipsmeier, C Simillion, A Bamdadian, R Tortelli, LM Byrne, YP Zhang, ...
Journal of Medical Internet Research 24 (6), e32997, 2022
192022
Deep learning-based human activity recognition for continuous activity and gesture monitoring for schizophrenia patients with negative symptoms
D Umbricht, WY Cheng, F Lipsmeier, A Bamdadian, M Lindemann
Frontiers in Psychiatry 11, 574375, 2020
172020
Towards improvement of MI-BCI performance of subjects with BCI deficiency
A Bamdadian, C Guan, KK Ang, J Xu
2015 7th International IEEE/EMBS Conference on Neural Engineering (NER), 17-20, 2015
132015
Generalized Predictive Control of depth of anesthesia by using a pharmocokinetic-pharmacodynamic model of the patient
A Bamdadian, F Towhidkhah, MH Moradi
2008 2nd International Conference on Bioinformatics and Biomedical …, 2008
112008
Hoehn and Yahr stage and striatal Dat-SPECT uptake are predictors of Parkinson’s disease motor progression
H Jackson, J Anzures-Cabrera, KI Taylor, G Pagano, C Altendorf, ...
Frontiers in neuroscience 15, 765765, 2021
92021
F61 Digital, high-frequency, long-term monitoring of motor and non-motor symptoms in huntington’s disease (hd) patients
F Lipsmeier, WY Cheng, D Wolf, YP Zhang, T Kilchenmann, A Bamdadian, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (Suppl 1), A61-A61, 2018
82018
Controlling the depth of anesthesia by using extended DMC
A Bamdadian, F Towhidkhah, B Marami
2008 Cairo International Biomedical Engineering Conference, 1-4, 2008
82008
Preliminary reliability and validity of a novel digital biomarker smartphone application to assess cognitive and motor symptoms in Huntington’s disease (HD)(P1. 8-042)
F Lipsmeier, C Simillion, A Bamdadian, A Smith, S Schobel, C Czech, ...
Neurology 92 (15 Supplement), 2019
72019
Real coded GA-based SVM for motor imagery classification in a Brain-Computer Interface
A Bamdadian, C Guan, KK Ang, J Xu
2011 9th IEEE International Conference on Control and Automation (ICCA …, 2011
62011
The Digital-HD study: smartphone-based remote testing to assess cognitive and motor symptoms in Huntington’s disease (1816)
R Tortelli, C Simillion, F Lipsmeier, T Kilchenmann, FB Rodrigues, ...
Neurology 94 (15 Supplement), 2020
52020
Reliability, feasibility and validity of a novel digital monitoring platform assessing cognitive and motor symptoms in people with Stage I and II Huntington’s disease (HD)
F Lipsmeier, C Simillion, A Bamdadian, A Smith, S Schobel, C Gossens, ...
Neurotherapeutics 16 (4), 1350-90, 2019
32019
TOWARDS PREDICTION AND IMPROVEMENT OF EEG-BASED MI-BCI PERFORMANCE.
A Bamdadian
22014
Remote monitoring of progression in early Parkinson’s disease: reliability and validity of the Roche PD Mobile Application v2
F Lipsmeier, KI Taylor, RB Postuma, E Volkova-Volkmar, T Kilchenmann, ...
medRxiv, 2021.10. 07.21264414, 2021
12021
Scaling the Roche Digital Health Technology Platform to assess disease severity and progression in individuals with Parkinson’s disease
W Popp, K Taylor, A Bamdadian, L Restelli, J Schjodt-Eriksen, G Pagano, ...
MOVEMENT DISORDERS 37, S347-S348, 2022
2022
Relationship of satisfaction and adherence in remote digital monitoring: Updated results from a clinical drug trial in early Parkinson’s disease
B Fehlmann, A Thomann, W Popp, F Lipsmeier, E Volkova-Volkmar, ...
MOVEMENT DISORDERS 37, S326-S327, 2022
2022
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20